ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729529; 2) Community: the network communities that were significantly associated with the response to NSC 729529; 3) Molecule: the relationships between components within communities and NSC 729529; 4) MDR: the compounds that were significantly associated with the NSC 729529.

NSC Compound Enrichment Correlation
NSC 100071 component of Halotex 0.030556149892922 0.31150695
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.030556149892922 0.41534839
NSC 142475 Null 0.030556149892922 0.2224734
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.030556149892922 0.48780354
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.030556149892922 0.29921568
NSC 180973 Tamoxifen citrate 0.030556149892922 0.14513089
NSC 285233 Null 0.030556149892922 0.086638461
NSC 308847 Amonafide 0.030556149892922 0.21580464
NSC 353739 Bismuthine, (acetyloxy)diphenyl- 0.030556149892922 0.26919683
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.030556149892922 0.51464118
Total:107  Current:66    [First] [Prev] [Next] [Last]